vs
Side-by-side financial comparison of AbbVie (ABBV) and Albertsons Companies, Inc. (ACI). Click either name above to swap in a different company.
Albertsons Companies, Inc. is the larger business by last-quarter revenue ($19.1B vs $15.0B, roughly 1.3× AbbVie). AbbVie runs the higher net margin — 4.6% vs 1.5%, a 3.1% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (9.9% vs 1.9%). Over the past eight quarters, Albertsons Companies, Inc.'s revenue compounded faster (3.3% CAGR vs 1.8%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Albertsons Companies, Inc. is an American grocery company founded and headquartered in Boise, Idaho.
ABBV vs ACI — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.0B | $19.1B |
| Net Profit | $697.0M | $293.3M |
| Gross Margin | — | 27.4% |
| Operating Margin | 26.6% | 2.6% |
| Net Margin | 4.6% | 1.5% |
| Revenue YoY | 9.9% | 1.9% |
| Net Profit YoY | -46.0% | -26.8% |
| EPS (diluted) | $0.39 | $0.55 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $15.0B | — | ||
| Q4 25 | $16.6B | $19.1B | ||
| Q3 25 | $15.8B | — | ||
| Q2 25 | $15.4B | $24.9B | ||
| Q1 25 | $13.3B | $18.8B | ||
| Q4 24 | $15.1B | $18.8B | ||
| Q3 24 | $14.5B | — | ||
| Q2 24 | $14.5B | $24.3B |
| Q1 26 | $697.0M | — | ||
| Q4 25 | $1.8B | $293.3M | ||
| Q3 25 | $186.0M | — | ||
| Q2 25 | $938.0M | $236.4M | ||
| Q1 25 | $1.3B | $171.8M | ||
| Q4 24 | $-22.0M | $400.6M | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.4B | $240.7M |
| Q1 26 | — | — | ||
| Q4 25 | 72.6% | 27.4% | ||
| Q3 25 | 66.4% | — | ||
| Q2 25 | 71.8% | 27.1% | ||
| Q1 25 | 70.0% | 27.4% | ||
| Q4 24 | 70.9% | 27.9% | ||
| Q3 24 | 70.9% | — | ||
| Q2 24 | 70.9% | 27.8% |
| Q1 26 | 26.6% | — | ||
| Q4 25 | 27.3% | 2.6% | ||
| Q3 25 | 12.1% | — | ||
| Q2 25 | 31.7% | 1.8% | ||
| Q1 25 | 28.0% | 1.5% | ||
| Q4 24 | -9.9% | 2.8% | ||
| Q3 24 | 26.5% | — | ||
| Q2 24 | 27.6% | 1.9% |
| Q1 26 | 4.6% | — | ||
| Q4 25 | 10.9% | 1.5% | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 6.1% | 1.0% | ||
| Q1 25 | 9.6% | 0.9% | ||
| Q4 24 | -0.1% | 2.1% | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 9.5% | 1.0% |
| Q1 26 | $0.39 | — | ||
| Q4 25 | $1.02 | $0.55 | ||
| Q3 25 | $0.10 | — | ||
| Q2 25 | $0.52 | $0.41 | ||
| Q1 25 | $0.72 | $0.29 | ||
| Q4 24 | $-0.03 | $0.69 | ||
| Q3 24 | $0.88 | — | ||
| Q2 24 | $0.77 | $0.41 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $195.1M |
| Total DebtLower is stronger | — | $8.4B |
| Stockholders' EquityBook value | — | $2.5B |
| Total Assets | — | $27.1B |
| Debt / EquityLower = less leverage | — | 3.36× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.3B | $195.1M | ||
| Q3 25 | $5.7B | — | ||
| Q2 25 | $6.5B | $151.0M | ||
| Q1 25 | $5.2B | $293.6M | ||
| Q4 24 | $5.6B | $202.3M | ||
| Q3 24 | $7.3B | — | ||
| Q2 24 | $13.2B | $291.1M |
| Q1 26 | — | — | ||
| Q4 25 | $58.9B | $8.4B | ||
| Q3 25 | $63.0B | — | ||
| Q2 25 | $63.0B | $7.0B | ||
| Q1 25 | $64.5B | $7.8B | ||
| Q4 24 | $60.3B | $7.8B | ||
| Q3 24 | $58.5B | — | ||
| Q2 24 | $58.0B | $7.8B |
| Q1 26 | — | — | ||
| Q4 25 | $-3.3B | $2.5B | ||
| Q3 25 | $-2.6B | — | ||
| Q2 25 | $-183.0M | $3.2B | ||
| Q1 25 | $1.4B | $3.4B | ||
| Q4 24 | $3.3B | $3.4B | ||
| Q3 24 | $6.0B | — | ||
| Q2 24 | $6.8B | $2.9B |
| Q1 26 | — | — | ||
| Q4 25 | $134.0B | $27.1B | ||
| Q3 25 | $133.9B | — | ||
| Q2 25 | $137.2B | $26.5B | ||
| Q1 25 | $136.2B | $26.8B | ||
| Q4 24 | $135.2B | $26.7B | ||
| Q3 24 | $143.4B | — | ||
| Q2 24 | $141.9B | $26.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.36× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.17× | ||
| Q1 25 | 45.44× | 2.29× | ||
| Q4 24 | 18.15× | 2.31× | ||
| Q3 24 | 9.70× | — | ||
| Q2 24 | 8.56× | 2.67× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $367.6M |
| Free Cash FlowOCF − Capex | — | $-94.7M |
| FCF MarginFCF / Revenue | — | -0.5% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | — | 1.25× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.2B | $367.6M | ||
| Q3 25 | $7.0B | — | ||
| Q2 25 | $5.2B | $754.4M | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $7.0B | $548.0M | ||
| Q3 24 | $5.4B | — | ||
| Q2 24 | $2.3B | $960.9M |
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $-94.7M | ||
| Q3 25 | $6.6B | — | ||
| Q2 25 | $4.9B | $169.8M | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $6.8B | $53.6M | ||
| Q3 24 | $5.2B | — | ||
| Q2 24 | $2.0B | $417.9M |
| Q1 26 | — | — | ||
| Q4 25 | 29.4% | -0.5% | ||
| Q3 25 | 42.1% | — | ||
| Q2 25 | 31.7% | 0.7% | ||
| Q1 25 | 10.5% | — | ||
| Q4 24 | 44.7% | 0.3% | ||
| Q3 24 | 35.9% | — | ||
| Q2 24 | 14.0% | 1.7% |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 2.4% | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 1.7% | 2.3% | ||
| Q1 25 | 1.8% | — | ||
| Q4 24 | 1.9% | 2.6% | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.7% | 2.2% |
| Q1 26 | — | — | ||
| Q4 25 | 2.87× | 1.25× | ||
| Q3 25 | 37.76× | — | ||
| Q2 25 | 5.49× | 3.19× | ||
| Q1 25 | 1.27× | — | ||
| Q4 24 | — | 1.37× | ||
| Q3 24 | 3.49× | — | ||
| Q2 24 | 1.66× | 3.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABBV
Segment breakdown not available.
ACI
| Retail Sales | $18.9B | 99% |
| Third Party Sales And Other Miscellaneous Revenue | $196.8M | 1% |
